| Literature DB >> 27717351 |
Gill Schierhout1, Veronica Matthews2, Christine Connors3, Sandra Thompson4, Ru Kwedza5, Catherine Kennedy6, Ross Bailie7.
Abstract
BACKGROUND: Addressing evidence-practice gaps in primary care remains a significant public health challenge and is likely to require action at different levels of the health system. Whilst Continuous Quality Improvement (CQI) is associated with improvements in overall delivery, little is known about delivery of different types of care processes, and their relative improvement during CQI.Entities:
Keywords: Clinical guidelines; Health systems; Impact; Primary care; Quality improvement
Mesh:
Year: 2016 PMID: 27717351 PMCID: PMC5055704 DOI: 10.1186/s12913-016-1812-9
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Recommended schedule for Type 2 diabetes patients by mode of care [6, 7]
| Mode of care/service item | Frequency | |
|---|---|---|
| Services for all type 2 diabetes clients | Laboratory Tests | |
| ACR | Yearly | |
| eGFR | Yearly | |
| Lipids | Yearly | |
| HbA1c | 3 monthly | |
| Generalist Physical Checks | ||
| Weight | 6 monthly | |
| Waist circumference | 6 monthly | |
| BMI | Yearly | |
| Blood Pressure | 3–6 monthly | |
| Visual acuity | Yearly | |
| Specialist Physical Checks | ||
| Dilated eye check | Yearly | |
| Foot check | Yearly | |
| Counselling | ||
| Nutrition | Yearly | |
| Physical activity | Yearly | |
| High risk substance use | Counselling | |
| Smoking | Yearly | |
| High risk alcohol consumption | Yearly | |
Characteristics of participating health centres by jurisdiction
| Far West New South Wales | Norther Territory | Queensland | South Australia | Western Australia | Total | ||
|---|---|---|---|---|---|---|---|
| Total number health centres | 6 | 65 | 69 | 8 | 14 | 162 | |
| Location | Remote | 3 (50) | 61 (94) | 46 (67) | 2 (25) | 7 (50) | 119 (73) |
| Non-remote | 3 (50) | 4 (6) | 23 (33) | 6 (75) | 7 (50) | 43 (27) | |
| Governance | Community-controlled | 6 (100) | 19 (29) | 1 (1) | 5 (63) | 8 (57) | 39 (24) |
| Government | 0 | 46 (71) | 68 (99) | 3 (37) | 6 (43) | 123 (76) | |
| Service Population | <501 | 2 (33) | 36 (55) | 34 (49) | 1 (12) | 2 (14) | 75 (46) |
| 501–999 | 1 (17) | 12 (18) | 14 (20) | 3 (38) | 0 | 30 (19) | |
| >999 | 3 (50) | 17 (26) | 21 (30) | 4 (50) | 12 (86) | 57 (35) | |
| Mean % (and range) clients attending last 6 months | 79 | 96 | 90 | 83 | 83 | 91 | |
| (53–97) | (77–100) | (60–100) | (62–100) | (50–100) | (50–100) | ||
| Duration of participation in ABCD CQI | <1 year | 0 | 9 (13) | 14 (20) | 2 (25) | 3 (21) | 28 (17) |
| 1–2 years | 0 | 27 (42) | 32 (46) | 5 (63) | 7 (50) | 71 (44) | |
| 3 or more years | 6 (100) | 29 (45) | 23 (33) | 1 (12) | 4 (29) | 63 (39) | |
Patient characteristics by jurisdiction (N and % unless otherwise indicated)
| Far West NSW | NT | QLD | SA | WA | Total | ||
|---|---|---|---|---|---|---|---|
| Total number health centres | 6 | 65 | 69 | 8 | 14 | 162 | |
| Location | Remote | 3 (50) | 61 (94) | 46 (67) | 2 (25) | 7 (50) | 119 (73) |
| Non-remote | 3 (50) | 4 (6) | 23 (33) | 6 (75) | 7 (50) | 43 (27) | |
| Governance | Community-controlled | 6 (100) | 19 (29) | 1 (1) | 5 (63) | 8 (57) | 39 (24) |
| Government | 0 | 46 (71) | 68 (99) | 3 (37) | 6 (43) | 123 (76) | |
| Service Population | <501 | 2 (33) | 36 (55) | 34 (49) | 1 (12) | 2 (14) | 75 (46) |
| 501–999 | 1 (17) | 12 (18) | 14 (20) | 3 (38) | 0 | 30 (19) | |
| >999 | 3 (50) | 17 (26) | 21 (30) | 4 (50) | 12 (86) | 57 (35) | |
| Mean % (and range) clients attending last 6 months | 79 | 96 | 90 | 83 | 83 | 91 | |
| (53–97) | (77–100) | (60–100) | (62–100) | (50–100) | (50–100) | ||
| Duration of participation in ABCD CQI | <1 year | 0 | 9 (13) | 14 (20) | 2 (25) | 3 (21) | 28 (17) |
| 1–2 years | 0 | 27 (42) | 32 (46) | 5 (63) | 7 (50) | 71 (44) | |
| 3 or more years | 6 (100) | 29 (45) | 23 (33) | 1 (12) | 4 (29) | 63 (39) | |
Fig. 1Type 2 diabetes service delivery over time by mode of care—(mean percent of the aggregate composite scores for each health centre for each mode of care)
Unadjusted multilevel logistic regression models of health centre and client level factors associated with top quartile delivery of guideline-scheduled services
| Laboratory testsa | Generalist physical checksa | Specialist physical checksa | Counselling or education (nutrition and physical activity)a | Counselling or education (high risk alcohol or tobacco use)b | ||
|---|---|---|---|---|---|---|
| Fixed effects | OR (95 % CI) | ORs (95 % CI) | ORs (95 % CI) | ORs (95 % CI) | ORs (95 % CI) | |
| Audit Year | 2005/2006 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| 2007 | 0.85 (0.71–1.05) | 2.45 (1.98–3.03)** | 0.88 (0.72–1.08) | 1.68 (1.38–2.04)** | 3.30 (2.23–4.88)** | |
| 2008 | 0.87 (0.72–1.04) | 3.20 (2.61–3.93)** | 0.95 (0.80–1.13) | 1.69 (1.41–2.01)** | 2.32 (1.67–3.21)** | |
| 2009 | 1.08 (0.90–1.29) | 5.09 (4.15–6.25)** | 1.26 (1.04–1.51)* | 2.69 (2.24–3.23)** | 2.33 (1.71–3.18)** | |
| 2010 | 1.23 (1.02–1.49(* | 5.11 (4.10–6.36)** | 1.06 (0.87–1.29) | 2.69 (2.22–3.26)** | 2.21 (1.59–3.09)** | |
| 2011 | 0.81 (0.69–0,97)** | 5.12 (4.19–6.2)** | 1.02 (0.85–1.21) | 2.14 (1.80–2.54)** | 2.25 (1.67–3.02)** | |
| 2012 | 1.26 (1.05–1.50)* | 6.65 (5.37–8.04)** | 1.29 (1.08–1.53)** | 2.18 (1.83–2.59)** | 2.25 (1.67–3.02)** | |
| 2013 | 1.67 (1.40–2.00)** | 9.77 (7.92–12.03)** | 1.64 (1.36–1.97)** | 2.43 (2.36–4.12)** | 2.76 (2.08–3.76)** | |
| 2014 | 1.82 (1.45–2.28)** | 9.57 (7.41–12.34)** | 1.65 (1.30–2.08)** | 2.48 (1.98–3.12)** | 2.41 (1.67–3.45)** | |
|
| ||||||
| Duration of CQI participation | Baseline | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| 1–2 cycles | 1.47*1.35–1.61)** | 2.40 (2.17–2.65)** | 1.40 (1.28–1.53)** | 1.89 (1.73–2.07)** | 1.59 (1.36–1.85)** | |
| ≥3 cycles | 1.54 (1.39–1.72)** | 4.13 (3.66–4.66)** | 1.48 (1.33–1.65)** | 1.79 (1.61–2.00)** | 1.77 (1.52–2.07)** | |
| Location of health centre | Non-remote | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |
| Remote | 4.01(2.84–5.68)** | 1.85 (1.25–2.74)** | 1.66 (1.25–2.22)** | 1.82 (1.26–2.63)** | 1.16 (0.87–1.56) | |
| Governance | Community-Controlled | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Government operated | 0.85 (0.54–1.33) | 0.99 (0.64–1.54) | 1.03 (0.74–1.43) | 1.18 (0.80–1.75) | 0.75 (0.57–0.98)* | |
| Service population | ≤500 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| >500– < 1000 | 1.08 (0.67–1.61) | 1.00 (0.65–1.54) | 0.88 (0.64–1.20) | 0.89 (0.60–1.32) | 0.94 (0.67–1.31) | |
| ≥1000 | 0.71 (0.49–1.04) | 0.66 (0.45–0.96) | 0.71 (0.54–0.93) | 0.68 (0.48–0.97) | 1.01 (0.76–1.34) | |
| % Clients attending in past 6 months | <97 % | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| ≥97 % | 1.59 (1.44–1.75)** | 1.73 (1.56–1.92)** | 1.61 (1.45–1.78)** | 1.48 (1.34–1.64)** | 1.13 (0.96–1.32) | |
|
| ||||||
| Sex | Male | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Female | 1.08 (0.97–1.11) | 0.99 (0.92–1.17) | 1.09 (1.02–1.17) | 1.00 (0.95–1.07) | 0.99 (0.74–1.12) | |
| Age | ≥15- < 25 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| ≥25- < 40 | 1.20 (0.91–1.57) | 1.08 (0.81–1.45) | 1.51 (1.15–1.96)** | 1.37 (1.05–1.79)** | 0.94 (0.59–1.48) | |
| ≥40- < 55 | 1.45 (1.11–1.88) | 1.50 (1.13–1.99)** | 2.26 (1.74–2.92)** | 1.58 (1.12–2.04)** | 1.05 (0.67–1.65) | |
| ≥55 | 1.62 (1.24–2.11)** | 1.62 (1.22–2.15)** | 3,27 (2,52–4.24)** | 1.57 (0.53–1.34) | 1.00 (0.63–1.58) | |
| Indigenous Status | Non-Indigenous | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Indigenous | 1.11 (0.94–1.30) | 1.35 (1.14–1.60)** | 1.15 (0.98–1.35) | 1.02 (0.87–1.19) | 1.17 (0.84–1.64) | |
| Comorbidity | None | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| One or more | 1.53 (1.41–1.67)** | 1.52 (1.39–1.66)** | 1.65 (1.52–1.79)** | 1.46 (1.35–1.58)** | 1.24 (1/11–1.39)** | |
| Complications | None | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| 1–2 complications | 1.27 (1.14–1.42)** | 1.25 (1.11–1.40)** | 2.62 (2.30–1.40)** | 1,24 (1.11–1.39)** | 1.12 (0.92–1.38) | |
| >2 complications | 1.35 (1.13–1.61)** | 1.00 (0.82–1.20) | 3.47 (2.76–4.35)** | 1.08 (0.91–1.30) | 1.19 (0.86–1.66) | |
a N = 15,622 clients and 162 health centres
b N = 5962 clients and 162 health centres
*p < 0.05
**p = <0.01
Adjusted multilevel logistic regression models of health centre and client level factors associated with top quartile delivery of guideline-scheduled counselling or education (for nutrition and physical activity) (N = 15,622 clients, 162 health centres
| Model A empty | Model B adjusted | Model C adjusted | ||
|---|---|---|---|---|
| Fixed effects | OR (95 % CI) | ORs (95 % CI) | ORs (95 % CI) | |
| Audit Year | 2005/2006 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| 2007 | 1.68 (1.38–2.04)** | 1.27 (1.03–1.57)* | 1.33 (1.08–1.64)** | |
| 2008 | 1.69 (1.41–2.01)** | 1.36 (1.11–1.68)** | 1.46 (1.18–1.80)** | |
| 2009 | 2.69 (2.24–3.23)** | 2.20 (1.76–2.74)** | 2.26 (1.81–2.82)** | |
| 2010 | 2.69 (2.22–3.26)** | 2.37 (1.82–3.00)** | 2.40 (1.89–3.03)** | |
| 2011 | 2.14 (1.80–2.54)** | 2.06 (1.62–2.61)** | 2.06 (1.62–2.61)** | |
| 2012 | 2.18 (1.83–2.59)** | 1.67 (1.27–2.18)** | 1.64 (1.26–2.15)** | |
| 2013 | 2.43 (2.86–4.12)** | 2.58 (1.93–3.44)** | 2.52 (1.89–3.36)** | |
| 2014 | 2.48 (1.98–3.12)** | 2.13 (1.54–2.96)** | 2.10 (1.51–2.91)** | |
|
| ||||
| Location X duration of CQI participation | ||||
| Non-remote | Baseline | 1.00 (reference) | 1.00 (reference) | |
| 1–2 cycles | 2.09 (1.72–2.53)** | 2.04 (1.68–2.47)** | ||
| ≥3 cycles | 0.92 (0.68–1.25) | 0.90 (0.66–1.22) | ||
| Remote | Baseline | 1.00 (reference) | 1.00 (reference) | |
| 1–2 cycles | 1.27 (0.84–1.91) | 1.31 (0.91–1.87) | ||
| ≥3 cycles | 2.41 (1.54–3.79)** | 2.47 (1.64–3.74)** | ||
| Governance | Community-Controlled | 1.00 (reference) | 1.00 (reference) | |
| Government operated | 0.85 (0.59–1.20) | 0.87 (0.62–1.22) | ||
| Service population | ≤500 | 1.00 (reference) | 1.00 (reference) | |
| 501–999 | 0.96 (0.66–1.41) | 0.95 (0.65–1.39) | ||
| ≥1000 | 0.80 (0.56–1.14) | 0.81 (0.57–1.14) | ||
| % Clients attending in past 6 months | <97 % | 1.00 (reference) | 1.00 (reference) | |
| ≥97 % | 1.30 (1.17–1.44)** | 1.29 (1.16–1.44)** | ||
|
| ||||
| Sex | Male | 1.00 (reference) | ||
| Female | 1.02 (0.95–1.09) | |||
| Age | ≥15- < 25 | 1.00 (reference) | ||
| ≥25- < 40 | 1.29 (0.99–1.70) | |||
| ≥40- < 55 | 1.41 (1.08–1.85)* | |||
| ≥55 | 1.36 (1.04–1.78)* | |||
| Indigenous Status | Non-Indigenous | 1.00 (reference) | ||
| Indigenous | 0.97 (0.83–1.14) | |||
| Comorbidity | None | 1.00 (reference) | ||
| One or more | 1.38 (1.27–1.51)** | |||
| Complications | No complications | 1.00 (reference) | ||
| 1–2 complications | 1.17 (1.05–1.31)** | |||
| >2 complications | 1.03 (0.86–1.24) | |||
| Random effects (intercepts) | ||||
| State (variance (SE)) | 0.12 (0.12) | 0.002 (0.02) | 0.0002 (0.005) | |
| MORSTATE | 1.38 | 1.04 | 1.01 | |
|
| - |
|
| |
| Health Centre (variance (SE)) | 0.77 (0.11) | 0.69 (0.10) | 0.68 (0.09) | |
| MORHC | 2.31 | 2.21 | 2.20 | |
|
| - |
|
| |
| State & Health Centre (variance) | 0.88 | 0.70 | 0.68 | |
| MORSTATE-HC | 2.45 | 2.22 | 2.20 | |
|
| - |
|
| |
| Patient (variance (SE)) | 0.62 (0.12) | 0.47 (0.12) | 0.27 (0.08) | |
MOR (Median odds ratio): odds of receiving ‘top quartile’ service delivery if patient was to change health centre or jurisdiction; PCV (Proportional change in variance): percent variation explained in odds for better health care delivery by introduction of health centre or patient level factors
*p < 0.05
**p = <0.01
Adjusted multilevel logistic regression models of health centre and client level factors associated with top quartile delivery of guideline-scheduled counselling or education (for smoking and alcohol risk reduction amongst high risk users) (N = 5496 clients, 162 health centres)
| Model A empty | Model B adjusted | Model C adjusted | ||
|---|---|---|---|---|
| Fixed effects | OR (95 % CI) | ORs (95 % CI) | ORs (95 % CI) | |
| Audit Year | 2005/2006 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| 2007 | 3.30 (2.23–4.88)** | 2.67 (1.77–4.03)** | 2.80 (1.85–4.22)** | |
| 2008 | 2.32 (1.67–3.21)** | 1.87 (1.31–2.67)** | 1.96 (1.37–2.81)** | |
| 2009 | 2.33 (1.71–3.18)** | 1.90 (1.34–2.69)** | 1.96 (1.38–2.78)** | |
| 2010 | 2.21 (1.59–3.09)** | 1.88 (1.30–2.74)** | 1.90 (1.31–2.76)** | |
| 2011 | 2.25 (1.66–3.05)** | 1.99 (1.41–2.82)** | 2.01 (1.42–2.85)** | |
| 2012 | 2.25 (1.67–3.02)** | 1.74 (1.19–2.54)** | 1.75 (1.20–2.56)** | |
| 2013 | 2.76 (2.03–3.76)** | 2.06 (1.39–3.06)** | 2.07 (1.40–3.07)** | |
| 2014 | 2.41 (1.67–3.45)** | 1.81 (1.15–2.86)* | 1.82 (1.16–2.88)** | |
|
| ||||
| Location X duration of CQI participation | ||||
| Non-remote | Baseline | 1.00 (reference) | 1.00 (reference) | |
| 1–2 cycles | 1.83 (1.29–2.59)** | 1.78 (1.26–2.53)** | ||
| ≥3 cycles | 1.71 (1.01–2.89)* | 1.64 (0.97–2.77) | ||
| Remote | Baseline | 1.00 (reference) | 1.00 (reference) | |
| 1–2 cycles | 0.94 (0.65–1.35) | 0.93 (0.65–1.35) | ||
| ≥3 cycles | 1.03 (0.61–1.75) | 1.04 (0.62–1.76) | ||
| Governance | Community-Controlled | 1.00 (reference) | 1.00 (reference) | |
| Government operated | 0.67 (0.50–0.91)* | 0.69 (0.51–0.94)* | ||
| Service population | ≤500 | 1.00 (reference) | 1.00 (reference) | |
| 501–999 | 0.92 (0.67–1.27) | 0.92 (0.66–1.27) | ||
| ≥1000 | 0.99 (0.74–1.34) | 1.00 (0.74–1.35) | ||
| % Clients attending in past 6 months | <97 % | 1.00 (reference) | 1.00 (reference) | |
| ≥97 % | 1.06 (0.90–1.26) | 1.05 (0.88–1.24) | ||
|
| ||||
| Sex | Male | 1.00 (reference) | ||
| Female | 1.00 (0.88–1.13) | |||
| Age | ≥15- < 25 | 1.00 (reference) | ||
| ≥25- < 40 | 0.90 (0.57–1.42) | |||
| ≥40- < 55 | 0.97 (0.62–1.53) | |||
| ≥55 | 0.92 (0.58–1.45) | |||
| Indigenous Status | Non-Indigenous | 1.00 (reference) | ||
| Indigenous | 1.07 (0.76–1.51) | |||
| Comorbidity | None | 1.00 (reference) | ||
| One or more | 1.23 (1.06–1.43)** | |||
| Disease severity | No complications | 1.00 (reference) | ||
| 1–2 complications | 1.10 (0.90–1.35) | |||
| >2 complications | 1.17 (0.84–1.64) | |||
| Random effects (intercepts) | ||||
| State (variance (SE)) | 0.01 (0.02) | 0.00007 (0.001) | 0.00008 (0.001) | |
| MORSTATE | 1.09 | 1.01 | 1.01 | |
|
| - |
|
| |
| Health Centre (variance (SE)) | 0.44 (0.08) | 0.35 (0.07) | 0.35 (0.07) | |
| MORHC | 1.88 | 1.76 | 1.75 | |
|
| - |
|
| |
| State & Health Centre (variance (SE)) | 0.44 | 0.35 | 0.35 | |
| MORSTATE-HC | 1.89 | 1.76 | 1.75 | |
|
| - |
|
| |
| Patient (variance (SE)) | 1.11 (0.16) | 1.13 (0.27) | 0.97 (0.35) | |
MOR (Median odds ratio): odds of receiving ‘top quartile’ service delivery if patient was to change health centre or jurisdiction; PCV (Proportional change in variance): percent variation explained in odds for better health care delivery by introduction of health centre or patient level factors
*p < 0.05
**p = <0.01
Adjusted multilevel logistic regression models of health centre and client level factors associated with top quartile delivery of guideline-scheduled specialist physical checks (N = 15,622 clients, 162 health centres)
| Model A empty | Model B adjusted | Model C adjusted | ||
|---|---|---|---|---|
| Fixed effects | OR (95 % CI) | ORs (95 % CI) | ORs (95 % CI) | |
| Audit Year | 2005/2006 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| 2007 | 0.88 (0.72–1.08) | 0.74 (0.60–0.91)** | 0.75 (0.60–0.93)** | |
| 2008 | 0.95 (0.80–1.13) | 0.78 (0.63–0.96)* | 0.83 (0.67–1.03) | |
| 2009 | 1.26 (1.04–1.51)* | 1.02 (0.82–1.27) | 1.05 (0.84–1.32) | |
| 2010 | 1.06 (0.87–1.29) | 0.86 (0.68–1.09) | 0.86 (0.68–1.10) | |
| 2011 | 1.02 (0.85–1.21) | 0.87 (0.69–1.10) | 0.86 (0.67–1.09) | |
| 2012 | 1.29 (1.08–1.53)* | 0.95 (0.73–1.24) | 0.95 (0.72–1.25) | |
| 2013 | 1.64 (1.36–1.97)** | 1.16 (0.87–1.54) | 1.09 (0.82–1.46) | |
| 2014 | 1.65 (1.30–2.08)** | 1.21 (0.87–1.68) | 1.13 (0.81–1.57) | |
|
| ||||
| Location X duration of CQI participation | ||||
| Non-remote | Baseline | 1.00 (reference) | 1.00 (reference) | |
| 1–2 cycles | 1.59 (1.32–1.91)** | 1.53 (1.26–1.84)** | ||
| ≥3 cycles | 1.26 (0.93–1.71) | 1.20 (0.88–1.65) | ||
| Remote | Baseline | 1.00 (reference) | 1.00 (reference) | |
| 1–2 cycles | 1.24 (0.91–1.68) | 1.36 (0.99–1.85) | ||
| ≥3 cycles | 1.55 (1.07–2.24)* | 1.70 (1.16–2.47)** | ||
| Governance | Community-Controlled | 1.00 (reference) | 1.00 (reference) | |
| Government operated | 0.89 (0.66–1.20) | 0.93 (0.68–1.26) | ||
| Service population | ≤500 | 1.00 (reference) | 1.00 (reference) | |
| 501–999 | 0.94 (0.70–1.26) | 0.94 (0.70–1.27) | ||
| ≥1000 | 0.86 (0.65–1.12) | 0.86 (0.65–1.14) | ||
| % Clients attending in past 6 months | <97 % | 1.00 (reference) | 1.00 (reference) | |
| ≥97 % | 1.47 (1.32–1.64)** | 1.46 (1.31–1.62)** | ||
|
| ||||
| Sex | Male | 1.00 (reference) | ||
| Female | 1.14 (1.06–1.23)** | |||
| Age | ≥15- < 25 | 1.00 (reference) | ||
| ≥25- < 40 | 1.40 (1.07–1.83)* | |||
| ≥40- < 55 | 1.92 (1.48–2.51)** | |||
| ≥55 | 2.66 (2.04–3.47)** | |||
| Indigenous Status | Non-Indigenous | 1.00 (reference) | ||
| Indigenous | 1.23 (1.05–1.45)* | |||
| Comorbidity | None | 1.00 (reference) | ||
| One or more | 1.35 (1.24–1.47)** | |||
| Disease severity | No complications | 1.00 (reference) | ||
| 1–2 complications | 2.34 (2.06–2.67)** | |||
| >2 complications | 3.08 (2.45–3.88)** | |||
| Random effects (intercepts) | ||||
| State (variance (SE)) | 0.36 (0.26) | 0.18 (0.14) | 0.18 (0.14) | |
| MORSTATE | 1.77 | 1.49 | 1.49 | |
|
| - |
|
| |
| Health Centre (variance (SE)) | 0.49 (0.07) | 0.38 (0.06) | 0.40 (0.06) | |
| MORHC | 1.95 | 1.80 | 1.83 | |
|
| - |
|
| |
| State & Health Centre (variance) | 0.85 | 0.56 | 0.57 | |
| MORSTATE-HC | 2.41 | 2.03 | 2.06 | |
|
| - |
|
| |
| Patient (variance (SE)) | 1.21 (0.35) | 1.00 (0.27) | 0.26 (0.08) | |
MOR (Median odds ratio): odds of receiving ‘top quartile’ service delivery if patient was to change health centre or jurisdiction; PCV (Proportional change in variance): percent variation explained in odds for better health care delivery by introduction of health centre or patient level factors
*p < 0.05
**p = <0.01
Adjusted multilevel logistic regression models of health centre and client level factors associated with top quartile delivery of guideline-scheduled laboratory tests (N = 15,622 clients, 162 health centres)
| Model A empty | Model B adjusted | Model C adjusted | ||
|---|---|---|---|---|
| Fixed effects | OR (95 % CI) | ORs (95 % CI) | ORs (95 % CI) | |
| Audit Year | 2005/2006 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| 2007 | 0.86 (0.71–1.05) | 0.77 (0.62–0.95)* | 0.80 (0.65–0.99)* | |
| 2008 | 0.87 (0.72–1.04) | 0.76 (0.61–0.93)** | 0.80 (0.65–0.99)* | |
| 2009 | 1.08 (0.90–1.29) | 0.92 (0.74–1.14) | 0.94 (0.75–1.17) | |
| 2010 | 1.23 (1.02–1.49)* | 1.03 (0.82–1.30) | 1.03 (0.82–1.30) | |
| 2011 | 0.81 (0.69–0.97)** | 0.73 (0.58–0.92)** | 0.72 (0.57–0.91)** | |
| 2012 | 1.26 (1.05–1.50)* | 1.01 (0.77–1.32) | 0.99 (0.75–1.29) | |
| 2013 | 1.67 (1.40–2.00)** | 1.28 (0.96–1.70) | 1.22 (0.92–1.63) | |
| 2014 | 1.82 (1.45–2.28)** | 1.49 (1.08–2.06)* | 1.44 (1.04–1.99)* | |
|
| ||||
| Location X duration of CQI participation | ||||
| Non-remote | Baseline | 1.00 (reference) | 1.00 (reference) | |
| 1–2 cycles | 1.03 (0.82–1.28) | 0.99 (0.79–1.23) | ||
| ≥3 cycles | 0.91 (0.66–1.26) | 0.87 (0.63–1.21) | ||
| Remote | Baseline | 1.00 (reference) | 1.00 (reference) | |
| 1–2 cycles | 4.43 (3.06–6.41)** | 4.59 (3.17–6.63)** | ||
| ≥3 cycles | 4.68 (3.07–7.14)** | 4.84 (3.18–7.37)** | ||
| Governance | Community-Controlled | 1.00 (reference) | 1.00 (reference) | |
| Government operated | 0.76 (0.53–1.08) | 0.78 (0.55–1.11) | ||
| Service population | ≤500 | 1.00 (reference) | 1.00 (reference) | |
| >500- < 1000 | 1.24 (0.88–1.76) | 1.23 (0.87–1.73) | ||
| ≥1000 | 1.16 (0.84–1.61) | 1.17 (0.84–1.61) | ||
| % Clients attending in past 6 months | <97 % | 1.00 (reference) | 1.00 (reference) | |
| ≥97 % | 1.39 (1.26–1.54)** | 1.38 (1.25–1.53)** | ||
|
| ||||
| Sex | Male | 1.00 (reference) | ||
| Female | 1.06 (0.99–1.14) | |||
| Age | ≥15- < 25 | 1.00 (reference) | ||
| ≥25- < 40 | 1.12 (0.85–1.47) | |||
| ≥40- < 55 | 1.27 (0.97–1.67) | |||
| ≥55 | 1.39 (1.06–1.82)* | |||
| Indigenous Status | Non-Indigenous | 1.00 (reference) | ||
| Indigenous | 1.07 (0.91–1.26) | |||
| Comorbidity | None | 1.00 (reference) | ||
| One or more | 1.38 (1.27–1.51)** | |||
| Complications | None | 1.00 (reference) | ||
| 1–2 complications | 1.18 (1.06–1.32)** | |||
| >2 complications | 1.24 (1.03–1.48)* | |||
| Random effects (intercepts) | ||||
| State (variance (SE)) | 0.51 (0.37) | 0.16 (0.13) | 0.15 (0.12) | |
| MORSTATE | 1.97 | 1.46 | 1.44 | |
|
| - |
|
| |
| Health Centre (variance (SE)) | 0.96 (0.14) | 0.56 (0.09) | 0.55 (0.09) | |
| MORHC | 2.55 | 2.04 | 2.02 | |
|
| - |
|
| |
| State & Health Centre (variance) | 1.470 | 0.717 | 0.692 | |
| MORSTATE-HC | 3.18 | 2.24 | 2.21 | |
|
| - |
|
| |
| Patient (variance (SE)) | 0.39 (0.14) | 0.19 (0.06) | 0.11 (0.03) | |
MOR (Median odds ratio): odds of receiving ‘top quartile’ service delivery if patient was to change health centre or jurisdiction; PCV (Proportional change in variance): percent variation explained in odds for better health care delivery by introduction of health centre or patient level factors
*p < 0.05
**p = <0.01
Adjusted multilevel logistic regression models of health centre and client level factors associated with top quartile delivery of guideline-scheduled generalist physical checks (N = 15,622 clients, 162 health centres)
| Model A empty | Model B adjusted | Model C adjusted | ||
|---|---|---|---|---|
| Fixed effects | OR (95 % CI) | ORs (95 % CI) | ORs (95 % CI) | |
| Audit Year | 2005/2006 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| 2007 | 2.45 (1.98–3.03)** | 1.75 (1.39–2.20)** | 1.82 (1.45–2.29)** | |
| 2008 | 3.20 (2.61–3.93)** | 1.97 (1.54–2.50)** | 2.10 (1.64–2.68)** | |
| 2009 | 5.09 (4.15–6.25)** | 2.96 (2.30–3.80)** | 3.05 (2.37–3.92)** | |
| 2010 | 5.11 (4.10–6.36)** | 2.87 (2.18–3.76)** | 2.89 (2.20–3.79)** | |
| 2011 | 5.12 (4.19–6.26)** | 2.99 (2.28–3.92)** | 2.99 (2.28–3.93)** | |
| 2012 | 6.56 (5.37–8.04)** | 2.86 (2.09–3.90)** | 2.86 (2.10–3.91)** | |
| 2013 | 9.77 (7.92–12.03)** | 3.86 (2.78–5.36)** | 3.81 (2.74–5.29)** | |
| 2014 | 9.57 (7.41–12.34)** | 3.86 (2.67–5.59)** | 3.79 (2.62–5.48)** | |
|
| ||||
| Location X duration of CQI participation | ||||
| Non-remote | Baseline | 1.00 (reference) | 1.00 (reference) | |
| 1–2 cycles | 1.77 (1.40–2.24)** | 1.71 (1.35–2.17)** | ||
| ≥3 cycles | 2.13 (1.49–3.03)** | 2.02 (1.42–2.89)** | ||
| Remote | Baseline | 1.00 (reference) | 1.00 (reference) | |
| 1–2 cycles | 1.36 (0.90–2.05) | 1.35 (0.90–2.04) | ||
| ≥3 cycles | 1.35 (0.84–2.15) | 1.35 (0.85–2.16) | ||
| Governance | Community-Controlled | 1.00 (reference) | 1.00 (reference) | |
| Government operated | 0.73 (0.48–1.11) | 0.74 (0.49–1.13) | ||
| Service population | ≤500 | 1.00 (reference) | 1.00 (reference) | |
| 501–999 | 1.01 (0.67–1.52) | 1.01 (0.67–1.51) | ||
| ≥1000 | 0.72 (0.49–1.05) | 0.71 (0.49–1.04) | ||
| % Clients attending in past 6 months | <97 % | 1.00 (reference) | 1.00 (reference) | |
| ≥97 % | 1.39 (1.25–1.55)** | 1.38 (1.23–1.54)** | ||
|
| ||||
| Sex | Male | 1.00 (reference) | ||
| Female | 1.02 (0.95–1.10) | |||
| Age | ≥15- < 25 | 1.00 (reference) | ||
| ≥25- < 40 | 1.09 (0.81–1.47) | |||
| ≥40- < 55 | 1.43(1.06–1.92)* | |||
| ≥55 | 1.52 (1.13–2.05)** | |||
| Indigenous Status | Non-Indigenous | 1.00 (reference) | ||
| Indigenous | 1.27 (1.06–1.51)** | |||
| Comorbidity | None | 1.00 (reference) | ||
| One or more | 1.31 (1.19–1.44)** | |||
| Complications | No complications | 1.00 (reference) | ||
| 1–2 complications | 1.16 (1.03–1.30)* | |||
| >2 complications | 0.90 (0.74–1.09) | |||
| Random effects (intercepts) | ||||
| State (variance (SE)) | 0.80 (0.55) | 0.39 (0.28) | 0.39 (0.28) | |
| MORSTATE | 2.34 | 1.82 | 1.82 | |
|
| - |
|
| |
| Health Centre (variance (SE)) | 0.90 (0.12) | 0.79 (0.11) | 0.78 (0.11) | |
| MORHC | 2.47 | 2.34 | 2.32 | |
|
| - |
|
| |
| State & Health Centre (variance) | 1.70 | 1.19 | 1.17 | |
| MORSTATE-HC | 3.47 | 2.83 | 2.81 | |
|
| - |
|
| |
| Patient (variance (SE)) | 0.11 (0.05) | 0.14 (0.05) | 0.07 (0.03) | |
MOR (Median odds ratio): odds of receiving ‘top quartile’ service delivery if patient was to change health centre or jurisdiction; PCV (Proportional change in variance): percent variation explained in odds for better health care delivery by introduction of health centre or patient level factors
*p < 0.05
**p = <0.01